Forecast: Total Pharmaceutical Spending in the US

In 2023, total pharmaceutical spending in the US was positioned at $1.51 thousand per capita. Projections indicate a consistent growth trajectory from 2024 to 2028, with a year-on-year increase of approximately 1.95% to 1.89%. Notably, the compound annual growth rate (CAGR) from 2024 to 2028 is approximately 1.95%. This upward trend suggests a steady increase in pharmaceutical spending per capita in the US over the five-year forecast period.

Future trends to watch for:

• Continued rise in specialty drug spending driven by the adoption of innovative therapies.
• Impact of regulatory changes on drug pricing and the broader pharmaceutical landscape.
• The influence of biosimilars and generics in curbing overall spending growth.